Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cremer

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Oncogene|March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cellsKarène Mahtouk, Dirk Hose, Thierry Rème, et al.
Leukemia|March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yieldI Breitkreutz, H M Lokhorst, M S Raab, et al.
Blood|April 14, 2005
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureJérôme Moreaux, Friedrich W Cremer, Thierry Reme, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
British Journal of Cancer|March 6, 2015
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesC P Kratz, L Franke, H Peters, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Oncogene|March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cellsKarène Mahtouk, Dirk Hose, Thierry Rème, et al.
Leukemia|March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yieldI Breitkreutz, H M Lokhorst, M S Raab, et al.
Blood|April 14, 2005
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureJérôme Moreaux, Friedrich W Cremer, Thierry Reme, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
British Journal of Cancer|March 6, 2015
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesC P Kratz, L Franke, H Peters, et al.
Pageof 8